Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation.

Tytuł :
Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation.
Autorzy :
Ataca Atilla, Pinar
Akkus, Erman
Atilla, Erden
Gokmen, Neslihan
Civriz Bozdag, Sinem
Kurt Yuksel, Meltem
Toprak, Selami Kocak
Baskal, Nilgun
Akan, Hamdi
Demirer, Taner
Topcuoglu, Pervin
Arslan, Onder
Ilhan, Osman
Ozcan, Muhit
Beksac, Meral
Gurman, Gunhan
Pokaż więcej
Temat :
HEMATOPOIETIC stem cell transplantation
THYROID gland function tests
Źródło :
Clinical Transplantation; Oct2020, Vol. 34 Issue 10, p1-6, 6p
Czasopismo naukowe
Introduction: Thyroid dysfunction (TD) is one of the major endocrinopathies shown after allogeneic hematopoietic stem cell transplantation over the long term. The incidence and the risk factors for TD have varied widely. Patients and Methods: Two hundred and fifty‐nine patients with pre‐transplant normal thyroid function tests who survived at least 1 year after allo‐HSCT between 2006‐2016 were included in the study. Results: Sixty‐four patients (25%) developed TD at median of 34 months (range, 1‐112 months). Hypothyroidism was detected in 32 patients (12%): 5 patients had primary hypothyroidism, and subclinical hypothyroidism occurred in 27 patients. 18 patients (7%) were diagnosed with hyperthyroidism: 2 patients (0.07%) were treated for primary hyperthyroidism, and 16 patients (6%) were followed for subclinical hyperthyroidism. Euthyroid sick syndrome occurred in 14 cases. None of the patients with thyroid dysfunction developed secondary thyroid malignancy. Receiving high‐dose TBI (P =.001) was found to be significant risk for hypothyroidism; older age than median (P =.01) and pre‐transplant active disease (P <.0001) were related to hyperthyroidism. Conclusions: Thyroid dysfunction, mostly hypothyroidism, is a long‐term complication after allo‐HSCT in 25% of patients. Older age, pre‐transplant active disease, and receiving TBI are among the risk factors. Sustained long‐term monitoring of thyroid function test should be considered post allo‐HSCT. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Transplantation is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies